Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Genes Dev
2012 Feb 01;263:282-93. doi: 10.1101/gad.180968.111.
Show Gene links
Show Anatomy links
A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting.
Hugo SE, Cruz-Garcia L, Karanth S, Anderson RM, Stainier DY, Schlegel A.
???displayArticle.abstract???
To find new genes that influence liver lipid mass, we performed a genetic screen for zebrafish mutants with hepatic steatosis, a pathological accumulation of fat. The red moon (rmn) mutant develops hepatic steatosis as maternally deposited yolk is depleted. Conversely, hepatic steatosis is suppressed in rmn mutants by adequate nutrition. Adult rmn mutants show increased liver neutral lipids and induction of hepatic lipid biosynthetic genes when fasted. Positional cloning of the rmn locus reveals a loss-of-function mutation in slc16a6a (solute carrier family 16a, member 6a), a gene that we show encodes a transporter of the major ketone body β-hydroxybutyrate. Restoring wild-type zebrafish slc16a6a expression or introducing human SLC16A6 in rmn mutant livers rescues the mutant phenotype. Radiotracer analysis confirms that loss of Slc16a6a function causes diversion of liver-trapped ketogenic precursors into triacylglycerol. Underscoring the importance of Slc16a6a to normal fasting physiology, previously fed rmn mutants are more sensitive to death by starvation than are wild-type larvae. Our unbiased, forward genetic approach has found a heretofore unrecognized critical step in fasting energy metabolism: hepatic ketone body transport. Since β-hydroxybutyrate is both a major fuel and a signaling molecule in fasting, the discovery of this transporter provides a new direction for modulating circulating levels of ketone bodies in metabolic diseases.
???displayArticle.pubmedLink???
22302940 ???displayArticle.pmcLink???PMC3278895 ???displayArticle.link???Genes Dev ???displayArticle.grants???[+]
Anderson,
Loss of Dnmt1 catalytic activity reveals multiple roles for DNA methylation during pancreas development and regeneration.
2009, Pubmed
Anderson,
Loss of Dnmt1 catalytic activity reveals multiple roles for DNA methylation during pancreas development and regeneration.
2009,
Pubmed Babin,
Plasma lipoproteins in fish.
1989,
Pubmed Bonen,
Distribution of monocarboxylate transporters MCT1-MCT8 in rat tissues and human skeletal muscle.
2006,
Pubmed Boukaftane,
Human mitochondrial HMG CoA synthase: liver cDNA and partial genomic cloning, chromosome mapping to 1p12-p13, and possible role in vertebrate evolution.
1994,
Pubmed Browning,
Molecular mediators of hepatic steatosis and liver injury.
2004,
Pubmed Cahill,
Fuel metabolism in starvation.
2006,
Pubmed Chakravarthy,
"New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis.
2005,
Pubmed Clark,
The epidemiology of nonalcoholic fatty liver disease in adults.
2006,
Pubmed Cohen,
Human fatty liver disease: old questions and new insights.
2011,
Pubmed Gibbons,
Mobilisation of triacylglycerol stores.
2000,
Pubmed Goodwin,
A new group of tyrosine recombinase-encoding retrotransposons.
2004,
Pubmed Guan,
Accelerated fatty acid oxidation in muscle averts fasting-induced hepatic steatosis in SJL/J mice.
2009,
Pubmed Gutierrez,
Specialized hepatocyte-like cells regulate Drosophila lipid metabolism.
2007,
Pubmed Hashimoto,
Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.
2000,
Pubmed Her,
In vivo studies of liver-type fatty acid binding protein (L-FABP) gene expression in liver of transgenic zebrafish (Danio rerio).
2003,
Pubmed Hooper,
Genetic determinants of hepatic steatosis in man.
2011,
Pubmed Ibabe,
Expression of peroxisome proliferator-activated receptors in zebrafish (Danio rerio).
2002,
Pubmed Kersten,
Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.
1999,
Pubmed Kulozik,
Hepatic deficiency in transcriptional cofactor TBL1 promotes liver steatosis and hypertriglyceridemia.
2011,
Pubmed Kwan,
The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs.
2007,
Pubmed Laeger,
Role of beta-hydroxybutyric acid in the central regulation of energy balance.
2010,
Pubmed Laffel,
Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes.
1999,
Pubmed Leblanc,
Novel aspects of the activities and subcellular distribution of enzymes of ketone body metabolism in the liver and kidney of the goldfish, Carassius auratus.
2000,
Pubmed Lin,
Hepatic triglyceride contents are genetically determined in mice: results of a strain survey.
2005,
Pubmed Liou,
Natural history of nonalcoholic steatohepatitis.
2006,
Pubmed Matthews,
TNFalpha-dependent hepatic steatosis and liver degeneration caused by mutation of zebrafish S-adenosylhomocysteine hydrolase.
2009,
Pubmed Miyake,
Mutation in the abcb7 gene causes abnormal iron and fatty acid metabolism in developing medaka fish.
2008,
Pubmed Mizuno,
A new enzymatic method for colorimetric determination of free fatty acids.
1980,
Pubmed Moller,
Fasting in healthy subjects is associated with intrahepatic accumulation of lipids as assessed by 1H-magnetic resonance spectroscopy.
2008,
Pubmed Nugent,
Evaluation and management of obesity-related nonalcoholic fatty liver disease.
2007,
Pubmed Phillips,
Ketogenesis in vertebrate livers.
1977,
Pubmed Pierre,
Monocarboxylate transporters in the central nervous system: distribution, regulation and function.
2005,
Pubmed Plata,
Zebrafish Slc5a12 encodes an electroneutral sodium monocarboxylate transporter (SMCTn). A comparison with the electrogenic SMCT (SMCTe/Slc5a8).
2007,
Pubmed
,
Xenbase Price,
Cloning and sequencing of four new mammalian monocarboxylate transporter (MCT) homologues confirms the existence of a transporter family with an ancient past.
1998,
Pubmed Raldúa,
Clofibrate and gemfibrozil induce an embryonic malabsorption syndrome in zebrafish.
2008,
Pubmed Rudel,
Determination of cholesterol using o-phthalaldehyde.
1973,
Pubmed Sadler,
A genetic screen in zebrafish identifies the mutants vps18, nf2 and foie gras as models of liver disease.
2005,
Pubmed Sanyal,
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
2010,
Pubmed Schlegel,
Microsomal triglyceride transfer protein is required for yolk lipid utilization and absorption of dietary lipids in zebrafish larvae.
2006,
Pubmed Schlombs,
Site-1 protease is required for cartilage development in zebrafish.
2003,
Pubmed Schnizler,
The roboocyte: automated cDNA/mRNA injection and subsequent TEVC recording on Xenopus oocytes in 96-well microtiter plates.
2003,
Pubmed
,
Xenbase Sengupta,
mTORC1 controls fasting-induced ketogenesis and its modulation by ageing.
2010,
Pubmed SNYDER,
A simplified spectrophotometric determination of ester groups in lipids.
1959,
Pubmed Thakur,
Lack of de novo phosphatidylinositol synthesis leads to endoplasmic reticulum stress and hepatic steatosis in cdipt-deficient zebrafish.
2011,
Pubmed Thisse,
High-resolution in situ hybridization to whole-mount zebrafish embryos.
2008,
Pubmed Veech,
The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism.
2004,
Pubmed Walters,
Muscle degeneration and leukocyte infiltration caused by mutation of zebrafish Fad24.
2009,
Pubmed Wu,
Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis.
2011,
Pubmed
